Bristol Myers Squibb is the latest large pharma company to be making a major bet on artificial intelligence,
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
The collaboration marks an “evolution” in the pharmaceutical giant’s use of AI and adds to a series of broad deals its peers have…
The biopharma company will use the AI model across research, drug development, manufacturing, and commercial and medical affairs
Doceree has bold ambitions to bring a new software category to pharma brand teams, one that reshapes campaign deployment in the…
Doximity plans to accelerate its spending on artificial intelligence this year as it aims to become a leading AI platform for…
There’s a thing that happens in American healthcare.You've got these massive systems—pharma conglomerates, hospital networks,…
Bristol Myers Squibb and Hengrui Pharma signed a massive deal worth up to $15.2 billion. Takeda aims to cut 4,500 jobs in fiscal…
Bristol Myers deepens AI investment with Anthropic deal
Bristol-Myers Squibb deploys Anthropic Claude to 30,000 employees
Doximity inks partnerships with Aledade, Photon as it ramps up AI spending in 2026
Turn Language Access into an Operational Advantage
Agentforce Life Sciences Now Used by More Than 140 Industry-Leading Organizations to Unify Health Engagement and Boost Outcomes
